Article

Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: Insights from Aotearoa New Zealand.

2022-10-24

Abstract excerpt

<title>Abstract</title> <p>Genomic technologies have become routine in the surveillance and monitoring of the Coronavirus Disease 2019 (COVID-19) pandemic, as evidenced by the millions of SARS-CoV-2 sequences uploaded to the Global Initiative on Sharing Avian Influenza Data (GISAID). Yet the ways in which these technologies have been applied to manage the pandemic are varied. Aotearoa New Zealand was one of a sma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: feee9c7a-d43a-5049-8642-9374acb48818
DOI: 10.21203/rs.3.rs-2180427/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: Insights from Aotearoa New Zealand.DOI 10.21203/rs.3.rs-2180427/v1Read

The power and limitations of genomics to track COVID-19 outbreaks: a case study from New ZealandSemantic proximity Read

Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New ZealandSemantic proximity Read

Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New ZealandSemantic proximity Read

Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New ZealandSemantic proximity Read

Use of Genomics to Track Coronavirus Disease Outbreaks, New ZealandSemantic proximity Read

Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New ZealandSemantic proximity Read

AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemicSemantic proximity Read

Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemicSemantic proximity Read

Are randomised controlled trials in the <i>BMJ</i> different?Semantic proximity Read

Genomic Surveillance for SARS-CoV-2 During the COVID-19 Pandemic: Collaborative Experience at Southeast MichiganSemantic proximity Read

COVID-19 Genomics UK (COG-UK) Consortium: Final ReportSemantic proximity Read

Development and scaling of a sequencing pipeline for genomic surveillance of SARS-CoV-2 in New York CitySemantic proximity Read